GSM112284[Accession] - GEO DataSets

Warning: The NCBI web site requires JavaScript to function. more...

Format

Summary
Summary (text)
Unique Identifier List

Sort by

Default order
Number of Samples (High to Low)
Number of Samples (Low to High)

Send to:

Choose Destination

File
Clipboard
Collections

Search results

Items: 4

Select item 2000049741.

thrombopoietin-induced megakaryocyte differentiation with and without nicotinamide

(Submitter supplied) Culture of hematopoietic stem and progenitor cells in the presence of thrombopoietin induces megakaryocytic differentiation. Addition of nicotinamide to thrombopoietin-stimulated cultures results in significant increases in megkaryocytic differentiation including greater polyploidization and enhanced proplatelet formation. This study focuses on understanding the differences in the temporal gene expression pattern during differentiation with and without nicotinamide. more...

Organism:: Homo sapiens

Type:: Expression profiling by array

Dataset:: GDS2513
Platform:: GPL887
28 Samples

Download data

Series

Accession:: GSE4974

ID:: 200004974

Select item 25132.

Nicotinamide effect on thrombopoietin-induced megakaryocyte differentiation in vitro

Analysis of thrombopoietin-cultured CD34+ cells at various time points up to 5 days following treatment with nicotinamide. Thrombopoietin induces CD34+ cells to differentiate into megakaryocytes. Results provide insight into the effect of nicotinamide on megakaryocyte differentiation.

Organism:: Homo sapiens

Type:: Expression profiling by array, log e ratio, 3 agent, 2 individual, 4 time sets

Platform:: GPL887
Series:: GSE4974
28 Samples

Download data

DataSet

Accession:: GDS2513

ID:: 2513

Select item 1000008873.

Agilent-012097 Human 1A Microarray (V2) G4110B (Feature Number version)

(Submitter supplied) Agilent's Human 1A Oligo Microarray (V2) includes over 20K 60-mer oligonucleotide probes, sourced from the Incyte Foundation Database, RefSeq, and GenBank, and are designed to span conserved exons across the transcripts of the targeted full length genes. Coupled with Agilent's probe selection and validation processes, this design method gives the customer maximum confidence in data quality and prevents redundancy in gene coverage. more...